2147: Hepatitis Serology Post-HCT

The Hepatitis Serology Post-HCT Data, Form 2147, will come due when the following IDMs are reported as “positive” on the Form 2000, Recipient Baseline Data:

• Hepatitis B surface antigen
• Hepatitis B core antibody
• Hepatitis B DNA
• Hepatitis C antibody
• Hepatitis C NAT
  

This form will also come due when a recipient’s post-transplant Hepatitis B and/or Hepatitis C viral infection is reported on the post-transplant follow-up forms for recipients on the comprehensive report form (CRF) track.
Links to Sections

• Q1-9: Serological Evidence of Hepatitis Exposure / Infection – Recipient
• Q10-17: Serological Evidence of Hepatitis Exposure / Infection – Donor
• Q18-37: Antiviral Therapy for Hepatitis
  

Manual Updates:
Sections of the Forms Instruction Manual are frequently updated. In addition to documenting the changes within each manual section, the most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.

Date	Manual Section	Add/Remove/Modify	Description
3/3/2021	2047/2147: Hepatitis Serology	Removed	Removed the following instructions as they are inaccurate: This form will also come due if a recipient received cells from a donor who was reported as “reactive” on the Form 2004, Infectious Disease Markers: Hepatitis B surface Antigen Hepatitis B core Antibody Hepatitis C Antibody
8/28/15	2047/2147: Hepatitis Serology	Add	Published new manual for 2047 & 2147 Hepatitis Serology.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.